R01HL153594
Project Grant
Overview
Grant Description
Functional Lung Imaging Using a Single KV CT Acquisition - Abstract
Venous thromboembolism is a major global health and economic burden with about 10 million cases occurring every year, and a high lifetime risk of 8% after age 45 years.
Pulmonary embolism (PE) is a venous thromboembolic event associated with high morbidity and mortality, with about 20% incidence of death before diagnosis or shortly thereafter.
Most recently, the COVID-19 pandemic has contributed to a marked increase in patients presenting with acute pulmonary thromboembolic disease, most likely created when the infectious vasculitis involving the endothelium creates local arterial thrombosis and subsequent lung infarction, with a superimposed hypercoagulable state that promotes clot formation.
In these patients, it is increasingly being recognized that pulmonary perfusion abnormalities associated with the lung consolidations and ground-glass opacities are important predictors of poor prognosis.
Currently, pulmonary CT angiography (CTA) has become the preferred method for diagnosing PE and planar lung ventilation/perfusion (V/Q) scintigraphy is used in cases when pulmonary CTA is contraindicated.
A compelling unmet clinical need is to develop a method for simultaneous pulmonary CTA and parenchymal perfusion assessment without the use of two modalities like CTA and SPECT perfusion in the same patient.
In this project, an imaging physics-based deep learning method will be developed to extract the previously overlooked spectral information inherently encoded in the acquired contrast-enhanced CT projection data.
As a result of this breakthrough, this new spectral CT imaging method, referred to as Deep-En-Chroma, will be developed and validated for perfusion defect quantification in lung parenchyma from the currently available pulmonary CTA.
This will be accomplished without the need for any expensive dual-energy CT (DECT) hardware upgrades that have been commercialized by major CT manufacturers.
In summary, upon the completion of this project, a new functional CT imaging method will have been developed, that in addition to providing the currently available pulmonary CTA images, will also detect perfusion defects in lung parenchyma without the requirement of high-end DECT hardware.
Venous thromboembolism is a major global health and economic burden with about 10 million cases occurring every year, and a high lifetime risk of 8% after age 45 years.
Pulmonary embolism (PE) is a venous thromboembolic event associated with high morbidity and mortality, with about 20% incidence of death before diagnosis or shortly thereafter.
Most recently, the COVID-19 pandemic has contributed to a marked increase in patients presenting with acute pulmonary thromboembolic disease, most likely created when the infectious vasculitis involving the endothelium creates local arterial thrombosis and subsequent lung infarction, with a superimposed hypercoagulable state that promotes clot formation.
In these patients, it is increasingly being recognized that pulmonary perfusion abnormalities associated with the lung consolidations and ground-glass opacities are important predictors of poor prognosis.
Currently, pulmonary CT angiography (CTA) has become the preferred method for diagnosing PE and planar lung ventilation/perfusion (V/Q) scintigraphy is used in cases when pulmonary CTA is contraindicated.
A compelling unmet clinical need is to develop a method for simultaneous pulmonary CTA and parenchymal perfusion assessment without the use of two modalities like CTA and SPECT perfusion in the same patient.
In this project, an imaging physics-based deep learning method will be developed to extract the previously overlooked spectral information inherently encoded in the acquired contrast-enhanced CT projection data.
As a result of this breakthrough, this new spectral CT imaging method, referred to as Deep-En-Chroma, will be developed and validated for perfusion defect quantification in lung parenchyma from the currently available pulmonary CTA.
This will be accomplished without the need for any expensive dual-energy CT (DECT) hardware upgrades that have been commercialized by major CT manufacturers.
In summary, upon the completion of this project, a new functional CT imaging method will have been developed, that in addition to providing the currently available pulmonary CTA images, will also detect perfusion defects in lung parenchyma without the requirement of high-end DECT hardware.
Awardee
Funding Goals
TO FOSTER HEART AND VASCULAR RESEARCH IN THE BASIC, TRANSLATIONAL, CLINICAL AND POPULATION SCIENCES, AND TO FOSTER TRAINING TO BUILD TALENTED YOUNG INVESTIGATORS IN THESE AREAS, FUNDED THROUGH COMPETITIVE RESEARCH TRAINING GRANTS. SMALL BUSINESS INNOVATION RESEARCH (SBIR) PROGRAM: TO STIMULATE TECHNOLOGICAL INNOVATION, USE SMALL BUSINESS TO MEET FEDERAL RESEARCH AND DEVELOPMENT NEEDS, FOSTER AND ENCOURAGE PARTICIPATION IN INNOVATION AND ENTREPRENEURSHIP BY SOCIALLY AND ECONOMICALLY DISADVANTAGED PERSONS, AND INCREASE PRIVATE-SECTOR COMMERCIALIZATION OF INNOVATIONS DERIVED FROM FEDERAL RESEARCH AND DEVELOPMENT FUNDING. SMALL BUSINESS TECHNOLOGY TRANSFER (STTR) PROGRAM: TO STIMULATE TECHNOLOGICAL INNOVATION, FOSTER TECHNOLOGY TRANSFER THROUGH COOPERATIVE R&D BETWEEN SMALL BUSINESSES AND RESEARCH INSTITUTIONS, AND INCREASE PRIVATE SECTOR COMMERCIALIZATION OF INNOVATIONS DERIVED FROM FEDERAL R&D.
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
Wisconsin
United States
Geographic Scope
State-Wide
Related Opportunity
Analysis Notes
Amendment Since initial award the total obligations have increased 298% from $759,616 to $3,023,272.
University Of Wisconsin System was awarded
Deep-En-Chroma: Innovative Lung Perfusion Imaging via Single KV CT
Project Grant R01HL153594
worth $3,023,272
from National Heart Lung and Blood Institute in July 2021 with work to be completed primarily in Wisconsin United States.
The grant
has a duration of 4 years and
was awarded through assistance program 93.837 Cardiovascular Diseases Research.
The Project Grant was awarded through grant opportunity NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed).
Status
(Complete)
Last Modified 1/6/25
Period of Performance
7/1/21
Start Date
6/30/25
End Date
Funding Split
$3.0M
Federal Obligation
$0.0
Non-Federal Obligation
$3.0M
Total Obligated
Activity Timeline
Transaction History
Modifications to R01HL153594
Additional Detail
Award ID FAIN
R01HL153594
SAI Number
R01HL153594-3655446087
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Public/State Controlled Institution Of Higher Education
Awarding Office
75NH00 NIH NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
Funding Office
75NH00 NIH NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
Awardee UEI
LCLSJAGTNZQ7
Awardee CAGE
09FZ2
Performance District
WI-90
Senators
Tammy Baldwin
Ron Johnson
Ron Johnson
Budget Funding
Federal Account | Budget Subfunction | Object Class | Total | Percentage |
---|---|---|---|---|
National Heart, Lung, and Blood Institute, National Institutes of Health, Health and Human Services (075-0872) | Health research and training | Grants, subsidies, and contributions (41.0) | $1,519,232 | 100% |
Modified: 1/6/25